Physician profile
Dmitriy Shore
NPI 1124177902
$3,398.50
in general payments reported to CMS, 2019-2025
16 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $17.50 · 2023: $397 · 2024: $1,423 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $700.22 | 2021-2025 | |
| Boston Scientific Corporation | $670.36 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Mml US, INC. | $325.75 | 2024-2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $302.34 | 2023-2024 | Xtampza, Belbuca |
| Pfizer INC. | $284.36 | 2023-2025 | |
| Abbott Laboratories | $277.91 | 2021-2025 | Proclaim, Eterna, Octrode |
| Biotronik Nro, INC. | $251.23 | 2023-2025 | Prospera, Biotronik |
| Globus Medical, INC. | $136.42 | 2025 | Senza, Omnia |
| Merz Pharmaceuticals, LLC | $113.15 | 2024-2025 | Xeomin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.20 | 2023-2025 | Relistor |
| Vertos Medical, INC. | $77.50 | 2023 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $62.49 | 2025 | |
| Azurity Pharmaceuticals, INC. | $48.13 | 2024-2025 | Horizant |
| Nalu Medical, INC. | $32.24 | 2021-2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $13.60 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.